Suppr超能文献

结直肠侧向发育型肿瘤中 K-ras、BRAF 和 PIK3CA 基因突变分析。

Analysis of K-ras, BRAF, and PIK3CA mutations in laterally-spreading tumors of the colorectum.

机构信息

Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.

出版信息

J Gastroenterol Hepatol. 2011 Mar;26(3):599-607. doi: 10.1111/j.1440-1746.2010.06485.x.

Abstract

BACKGROUND AND AIMS

Laterally-spreading tumors (LST) are a newly-recognized category of colorectal neoplasia, and are defined as lesions larger than 10 mm in diameter and extending circumferentially rather than vertically. However, genetic features of this new category of tumors are not fully elucidated. The aim of this study was to evaluate genetic alterations in LST.

METHODS

We examined K-ras, BRAF, and phosphoinositide-3-kinase catalytic-α polypeptide (PIK3CA) mutations in 101 LST, including 68 LST-granular type (LST-G) and 33 LST-non-granular type by direct sequencing. As controls, we examined these gene mutations in 66 protruded colon adenomas (10 mm or larger) and 44 advanced colon cancers.

RESULTS

K-ras, BRAF, and PIK3CA mutations were observed in 59 (58%), zero (0%), and three (3%) LST, respectively. LST-G morphology in the right-sided colon was significantly correlated with the existence of K-ras mutations, whereas a size of 20 mm or larger was the only predictor of mutations in the left-sided colorectum. The frequency of K-ras mutations in LST was particularly marked in the left-sided colorectum compared to protruded adenomas or advanced cancers (LST vs protruded adenomas, P < 0.001; LST vs advanced cancers, P = 0.002), whereas in the right-sided colon, K-ras mutations were equally frequent. PIK3CA mutations were not familiar in either LST (3%) or advanced cancers (9%).

CONCLUSIONS

K-ras mutations were involved in colorectal LST in different manners according to tumor location.

摘要

背景与目的

侧向伸展型肿瘤(LST)是一种新识别的结直肠肿瘤类别,其定义为直径大于 10mm 且呈环形而非纵向延伸的病变。然而,这种新肿瘤类别的遗传特征尚未完全阐明。本研究旨在评估 LST 的遗传改变。

方法

我们通过直接测序,检测了 101 例 LST(包括 68 例 LST-颗粒型[LST-G]和 33 例 LST-非颗粒型)中的 K-ras、BRAF 和磷酸肌醇-3-激酶催化-α多肽(PIK3CA)突变。作为对照,我们检测了 66 例直径大于 10mm 的隆起型结肠腺瘤和 44 例晚期结肠癌中的这些基因突变。

结果

LST 中观察到 K-ras、BRAF 和 PIK3CA 突变分别为 59(58%)、0(0%)和 3(3%)例。右侧结肠的 LST-G 形态与 K-ras 突变的存在显著相关,而 20mm 或更大的大小是左半结肠突变的唯一预测因素。与隆起型腺瘤或晚期癌症相比,LST 中 K-ras 突变的频率在左半结肠中尤其明显(LST 与隆起型腺瘤相比,P < 0.001;LST 与晚期癌症相比,P = 0.002),而在右半结肠中,K-ras 突变的频率相当。PIK3CA 突变在 LST(3%)或晚期癌症(9%)中均不常见。

结论

根据肿瘤位置的不同,K-ras 突变以不同的方式参与结直肠 LST。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验